Ownership signal 1 signal
Subject security 2 source fields
Symbol
LFCR
Shares outstanding
39,724,940 shares
SEC evidence 5 source fields
Form type
SCHEDULE 13D/A
Accepted by SEC
29 May 2025, 21:56:36 UTC
Event date
27 May 2025
Previous filing
26 Dec 2024
SEC filing
View on sec.gov

Key filing fact

22NW Fund, LP disclosed 7.5% ownership in Lifecore Biomedical, Inc. Common Stock, par value $0.001 per share (LFCR) on 27 May 2025.

Key facts

  • 22NW Fund, LP filed SCHEDULE 13D/A for Lifecore Biomedical, Inc. Common Stock, par value $0.001 per share (LFCR).
  • Disclosed ownership: 7.5%.
  • Date of event: 27 May 2025.

Change

  • Previous schedule filing date: 26 Dec 2024.
  • Current filing was accepted on 29 May 2025, 21:56.

Research use

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Evidence

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting persons

Reporting managers (7)

Names, ownership, voting power, signatures, titles, and CIKs as disclosed in this Schedule 13D/G filing.

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
22NW Fund, LP 7.5% 2,975,398 2,975,398 0 /s/ Aron R. English Manager 0001640809
22NW, LP 7.5% 2,975,398 2,975,398 0 /s/ Aron R. English President and Sole Shareholder 0001694297
22NW Fund GP, LLC 7.5% 2,975,398 2,975,398 0 /s/ Aron R. English Manager 0001770575
22NW GP, Inc. 7.5% 2,975,398 2,975,398 0 /s/ Aron R. English President and Sole Shareholder 0001783663
Aron R. English 7.5% 2,975,398 2,975,398 0 /s/ Aron R. English Individually and as attorney-in-fact for Nathaniel Calloway 0001770436
Bryson O. Hirai-Hadley 0% 583 583 0 /s/ Bryson O. Hirai-Hadley Bryson O. Hirai-Hadley 0001888106
Nathaniel Calloway 0% 0 0 0 /s/ Aron R. English As attorney-in-fact for Nathaniel Calloway 0001952771
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .